000 01154nam##2200265za#4500
0019.620226
003CaOODSP
00520200401020321
007ta
008150406|2011||||xxc|||||     f|0| 0 eng|d
020 |a978-1-100-19401-1
022 |a0821-8110
040 |aCaOODSP|beng
043 |an-cn---
0861 |aFA1-2011/2-4E
1101 |aCanada. |bOffice of the Auditor General.
24510|aReport of the Auditor General of Canada to the House of Commons. Chapter 4, : |bRegulating pharmaceutical drugs - Health Canada
260 |aOttawa - Ontario : |bOffice of the Auditor General of Canada
300 |aiii, 38p. : |btables ; |c28 cm.
4901 |aReport of the Auditor General of Canada to the House of Commons|x0821-8110|vFall 2011
563 |aSoftcover
590 |a12-07|b2012-02-17
77508|tRapport du vérificateur général du Canada à la Chambre des communes. Chapitre 4, : |w(CaOODSP)9.628879
7760#|tReport of the Auditor General of Canada to the House of Commons. Chapter 4, : |w(CaOODSP)9.571770
830#0|aReport of the Auditor General of Canada to the House of Commons,|x0821-8110|vFall 2011|w(CaOODSP)9.515730